ONE TOUCH VITA METER
Report
- Report Number
- 2939301-2008-02540
- Event Type
- Injury
- Date Received
- October 6, 2008
- Date of Event
- September 27, 2008
- Report Date
- September 29, 2008
- Manufacturer
- LIFESCAN, INC.
- Product Code
- NBW
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- LAY USER/PATIENT
Narratives
LIFESCAN HAS REQUESTED THE RETURN OF THE SUBJECT PRODUCTS FOR EVAL, BUT HAS NOT YET RECEIVED THEM. IF EITHER THE METER OR TEST STRIPS ARE RETURNED, LIFESCAN WILL EVALUATE THEM.
IN 2008, THE LAY USER/PT CONTACTED LIFESCAN (LFS) ALLEGING THE ONE TOUCH VITA METER WAS GIVING INACCURATELY HIGH READINGS. ON OCT. 1, 2008, THE TECHNICAL SERVICE REP (TSR) SPOKE WITH THE PT TO OBTAIN AND VERIFY INFO. ON TWO DAYS PRIOR TO ORIGINAL DATE, AT 11:00 PM, THE PT REPORTEDLY OBTAINED THE BLOOD GLUCOSE READING OF 274 MG/DL ON THE REPORTED METER, WHICH WAS HIGH COMPARED TO HER EXPECTED VALUES. THE PT HAD BEEN USING THIS PLASMA-CALIBRATED METER FOR A FEW DAYS; HER PREVIOUS METER WAS A WHOLE BLOOD-CALIBRATED METER (ONE TOUCH BASIC). AT THAT TIME, THE PT WAS NOT EXPERIENCING ANY SYMPTOMS OF HIGH OR LOW BLOOD GLUCOSE LEVELS. BASED ON THIS READING, THE PT TOOK SEVEN UNITS HUMINSULIN INSULIN. ON THE NEXT DAY AT 3:00AM, THE PT AWOKE ALLEGEDLY EXPERIENCING THE SYMPTOMS OF SWEATING AND NAUSEA. SHE DID NOT TEST HER BLOOD GLUCOSE LEVEL WHILE SYMPTOMATIC. THE PT ADMINISTERED SELF-TREATMENT BY TAKING GLUCOSE AND FELT BETTER AFTERWARDS. SHE DID NOT SEEK ANY MEDICAL ATTENTION. EARLIER ON THE DAY OF THE EVENT (7:30 AM) THE PT HAD OBTAINED A FASTING BLOOD GLUCOSE READING OF 102 MG/DL, AND TOOK THREE UNITS HUMINSULIN INSULIN. THE PT HAD EATEN HER NORMAL MEALS DURING THE DAY, ALTHOUGH AT LATER THAN USUAL TIMES. THE PT TAKES HUMINSULIN INSULIN THREE UNITS IN THE MORNING AND SIX TO SEVEN UNITS IN THE EVENING, ADJUSTING THESE DOSES BASED ON METER READINGS. THE PT TESTS TWICE PER DAY, AND WAS UNABLE TO STATE HER EXPECTED VALUES. THE PT WAS NOT AWARE OF THE 10% TO 12 % HIGHER VALUES OBTAINED WITH PLASMA-CALIBRATED METERS VERSUS WHOLE BLOOD-CALIBRATED METERS. HER TARGET VALUES HAD NOT BEEN ADJUSTED DUE TO THE USE OF THE NEW METER. DURING THE TROUBLESHOOTING TELEPHONE CALL, THE TSR DETERMINED THE PT'S TESTING TECHNIQUE WAS CORRECT AND THE METER WAS PROGRAMMED FOR THE CORRECT UNIT OF MEASURE. THE METER, TEST STRIPS AND CONTROL SOLUTION WERE REPLACED. THE PT ALLEGED SHE DID NOT UNDERSTAND THE PLASMA-CALIBRATED READINGS ON THE REPORTED METER WOULD BE HIGH COMPARED TO HER PREVIOUS WHOLE BLOOD-CALIBRATED METER, AND TOOK AN INSULIN DOSE BASED ON THIS READING. THE PT EXPERIENCED SYMPTOMS SUGGESTIVE OF HYPOGLYCEMIA AND RECEIVED SELF-TREATMENT WITH GLUCOSE TO RESOLVE THOSE SYMPTOMS. THEREFORE, THIS COMPLAINT IS BEING REPORTED AS AN ADVERSE EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ONE TOUCH VITA METER | GLUCOSE MONITORING SYS/KIT | NBW | LIFESCAN, INC. | NA | NOT PROVIDED |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Life Threatening| R |